Abstract 319 Table 1

Global patients

Patients total N (%) 63 (100)
Age median (range) 59 (29-78)
Primary tumor
Ovarian carcinoma
Endometrial carcinoma
Cervical carcinoma
Uterine sarcoma
Vaginal carcinoma
Bartholin’s gland adenocarcinoma
17 (27)
5 (8)
33 (52)
4 (6)
1 (2)
2 (3)
Target therapy 10 (16)